StoneRidge PMG Advisors, LLC’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Other funds holding INO
StoneRidge PMG Advisors, LLC's INO Position: Q1 2020 in Review
StoneRidge PMG Advisors, LLC sold out of Inovio Pharmaceuticals (INO) in Q1 2020, closing a stake of 1,410 shares — an estimated $56K sold.
StoneRidge PMG Advisors, LLC first reported a position in INO in Q3 2014 and held it in 18 quarters. The position peaked at $4.26M in Q2 2015. 157 funds tracked by Wall St. Rank hold INO as of Q1 2020.
- StoneRidge PMG Advisors, LLC reported no remaining Inovio Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- StoneRidge PMG Advisors, LLC sold 1,410 Inovio Pharmaceuticals shares in Q1 2020, an estimated $56K.
- StoneRidge PMG Advisors, LLC first reported a position in Inovio Pharmaceuticals in Q3 2014 and held it in 18 quarters.
- StoneRidge PMG Advisors, LLC's Inovio Pharmaceuticals position peaked at $4.26M in Q2 2015.
- 157 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2020.
Based on StoneRidge PMG Advisors, LLC's 13F filing for Q1 2020, filed 5 May 2020.